Home › Castration-Resistant Prostatic Cancer › Virginia › Arlington
Castration-Resistant Prostatic Cancer clinical trials in Arlington, VA
3 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 3
- Virginia Cancer Specialists, Fairfax · 11 mi away
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
RecruitingPhase 3
- Virginia Cancer Specialists, Fairfax · 11 mi away
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
RecruitingPhase 1
- Investigational Site number: 404, Fairfax · 11 mi away
Castration-Resistant Prostatic Cancer trials in other cities
- Los Angeles, CA8 studies
- New York City, NY7 studies
- Seattle, WA6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Philadelphia, PA4 studies
- Queens, NY4 studies
- Pittsburgh, PA4 studies
- Mountain View, CA3 studies
- San Francisco, CA3 studies
- Minneapolis, MN3 studies
- Baltimore, MD3 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)48 studies
- Breast Cancer46 studies
- Ovarian Cancer46 studies
- Lung Cancer41 studies
- Endometrial Cancer39 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma26 studies
- Small Cell Lung Cancer23 studies
- Triple-Negative Breast Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.